Literature DB >> 30537549

Direct HLA Genetic Comparisons Identify Highly Matched Unrelated Donor-Recipient Pairs with Improved Transplantation Outcome.

Ibrahim Vazirabad1, Saurabh Chhabra2, James Nytes1, Vatsal Mehra1, Ravi K Narra2, Aniko Szabo3, James H Jerkins2, Binod Dhakal2, Parameswaran Hari2, Matthew W Anderson4.   

Abstract

HLA matching by allele-level genotyping is largely based on genetic similarity between a few exons that encode the antigen recognition domain (ARD) of the HLA protein. Next-generation sequencing (NGS) can identify HLA genetic polymorphisms in non-ARD-encoding exons, introns, and untranslated regions, but the impact of these polymorphisms on hematopoietic cell transplantation (HCT) outcome is unclear. We performed NGS-based sequencing of 11 HLA loci on a well-characterized retrospective cohort of 166 unrelated donor-recipient HCT pairs. Genetic differences between HCT pairs were identified and visualized using a novel bioinformatics approach that directly compares phased full-length HLA sequences. Our approach was able to correctly classify HCT pairs without known HLA allele-level mismatches and also to identify a subset of HLA allele-matched HCT pairs with very few to no genetic differences in the sequenced HLA regions. This highly HLA genetically matched unrelated HCT group shows improved overall survival and reduced acute graft-versus-host disease compared with HCT pairs with HLA allele-level mismatches. These results suggest that direct genetic matching of HLA loci may offer an additional means of HCT donor selection beyond traditional HLA allele comparisons and suggests that genetic similarity as defined by HLA sequencing may have a novel role in unrelated HCT donor selection. Finally, our approach can enable larger cohort studies with adequate power to detect differences in other HCT outcomes based on genetic similarity within the HLA loci.
Copyright © 2018 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allogeneic transplantation; HLA; Next-generation sequencing; Unrelated donor

Mesh:

Substances:

Year:  2018        PMID: 30537549     DOI: 10.1016/j.bbmt.2018.12.006

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  6 in total

1.  Resolving MiSeq-Generated Ambiguities in HLA-DPB1 Typing by Using the Oxford Nanopore Technology.

Authors:  Jamie L Duke; Timothy L Mosbruger; Deborah Ferriola; Nilesh Chitnis; Taishan Hu; Nikolaos Tairis; David J Margolis; Dimitri S Monos
Journal:  J Mol Diagn       Date:  2019-06-04       Impact factor: 5.568

Review 2.  Humanized Mouse Models for Evaluation of PSC Immunogenicity.

Authors:  Jack Hermsen; Matthew E Brown
Journal:  Curr Protoc Stem Cell Biol       Date:  2020-09

3.  Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation.

Authors:  Neema P Mayor; Tao Wang; Stephanie J Lee; Michelle Kuxhausen; Cynthia Vierra-Green; Dominic J Barker; Jeffrey Auletta; Vijaya R Bhatt; Shahinaz M Gadalla; Loren Gragert; Yoshihiro Inamoto; Gerald P Morris; Sophie Paczesny; Ran Reshef; Olle Ringdén; Bronwen E Shaw; Peter Shaw; Stephen R Spellman; Steven G E Marsh
Journal:  J Clin Oncol       Date:  2021-04-09       Impact factor: 50.717

4.  Performance of a multiplexed amplicon-based next-generation sequencing assay for HLA typing.

Authors:  Chang Liu; Brian F Duffy; Eric T Weimer; Maureen C Montgomery; Jo-Ellen Jennemann; Rachel Hill; Donna Phelan; Lindsay Lay; Bijal A Parikh
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

5.  Personalized HLA typing leads to the discovery of novel HLA alleles and tumor-specific HLA variants.

Authors:  Irantzu Anzar; Angelina Sverchkova; Pubudu Samarakoon; Espen Basmo Ellingsen; Gustav Gaudernack; Richard Stratford; Trevor Clancy
Journal:  HLA       Date:  2022-02-10       Impact factor: 8.762

Review 6.  Immunogenetics in stem cell donor registry work: The DKMS example (Part 1).

Authors:  Alexander H Schmidt; Jürgen Sauter; Daniel M Baier; Jessica Daiss; Andreas Keller; Anja Klussmeier; Thilo Mengling; Gabi Rall; Tobias Riethmüller; Gerhard Schöfl; Ute V Solloch; Tigran Torosian; David Means; Helen Kelly; Latha Jagannathan; Patrick Paul; Anette S Giani; Sabine Hildebrand; Stephan Schumacher; Jan Markert; Monika Füssel; Jan A Hofmann; Thomas Schäfer; Julia Pingel; Vinzenz Lange; Johannes Schetelig
Journal:  Int J Immunogenet       Date:  2020-01-06       Impact factor: 1.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.